Diabetes

Latest News

April 11th 2013

Targeting Insulin Resistance: The Ongoing Paradigm Shift in Diabetes Prevention

By Tara Dall, MD, Dawn Thiselton, PhD, Stephen Varvel, PhD

April 9th 2013

Episode 25 - Closing Remarks

April 9th 2013

Episode 24 - Accountable Care Organizations

April 9th 2013

Episode 23 - The Affordable Care Act and Healthcare Reform

April 9th 2013

Episode 22 - Antiplatelet Agents Explored

Episode 21 - Expectations for Newly Developing Agents

April 9th 2013

Episode 20 - Pharmacotherapeutic Initiatives

April 9th 2013

Episode 19 - - Initiatives Aim to Control Cardiometabolic Events

April 9th 2013

Episode 18 - Impact of Obesity on Cardiometabolic Events

April 9th 2013

Episode 17 - Evolving Guidelines for the Treatment of Cardiometabolic Events

April 9th 2013

Episode 16- Exploring the Benefits and Limitations of Available Agents

April 9th 2013

Episode 15- Assessing the Factors at Increased Risk for Cardiometabolic Events

April 9th 2013

Episode 14- Recent Trends in the Epidemiology of Cardiometabolic Conditions

April 9th 2013

Episode 13- Current Developments of Pharmacotherapeutic Spending

April 9th 2013

Episode 12- Comparing Current Healthcare Spending to Patient Outcomes

April 9th 2013

Episode 11- Future Outlook on Preventive Care

April 9th 2013

Episode 10 - Drivers of Cost in Cardiometabolic Management

April 9th 2013

Episode 9 - Current Challenges and Gaps in Patient Care

April 9th 2013

Episode 8 - A Diverse Patient Population and Its Challenges

April 9th 2013

Episode 7 - The Complex Equation of Management

April 9th 2013

Episode 6 - Diabetes and the Burden of Disease

April 9th 2013

Episode 5 - Setting the Tone: Current Therapeutic Goals

April 9th 2013

Episode 4 - The Link Between Diabetes and Cardiovascular Disease

April 9th 2013

Episode 2 - The Challenges of Disease Management: Clinician and Provider Perspectives

April 9th 2013

Episode 3 - The Diversity of Patient Populations

April 9th 2013

Episode 1 - The Prevalence of Comorbid Cardiometabolic Disorders in the US

April 9th 2013

Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants

ByWilliam H. Herman, MD, MPH,Sharon L. Edelstein, ScM,Robert E. Ratner, MD,Maria G. Montez, RN, MSHP,Ronald T. Ackermann, MD, MPH,Trevor J. Orchard, MD,Mary A. Foulkes, PhD,Ping Zhang, PhD,Christopher D. Saudek, MD&dagger,Morton B. Brown, PhD,The Diabetes Prevention Program Research Group

March 13th 2013

Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.

Michael Farkouh, MD, Talks about the Prevention of Diabetes Mellitus

March 11th 2013

Michael Farkouh, MD, Director of Clinical Trials and Associate Professor of Medicine, Mount Sinai School of Medicine, says that there are many strategies to both prevent and control diabetes mellitus, but he notes that obesity prevention is key.

Diabetes Costs Nation $245 Billion Annually, Study Says

March 7th 2013

Type 2 Diabetes and the Evolving Paradigm in Glucose Regulation

ByMuhammad A. Abdul-Ghani, MD, PhD

February 17th 2013

Diabetes

Latest News

Episode 21 - Expectations for Newly Developing Agents

Episode 20 - Pharmacotherapeutic Initiatives

Episode 19 - - Initiatives Aim to Control Cardiometabolic Events

Episode 18 - Impact of Obesity on Cardiometabolic Events

Episode 17 - Evolving Guidelines for the Treatment of Cardiometabolic Events

Episode 16- Exploring the Benefits and Limitations of Available Agents

Episode 15- Assessing the Factors at Increased Risk for Cardiometabolic Events

Episode 14- Recent Trends in the Epidemiology of Cardiometabolic Conditions

Episode 13- Current Developments of Pharmacotherapeutic Spending

Episode 12- Comparing Current Healthcare Spending to Patient Outcomes

Episode 11- Future Outlook on Preventive Care

Episode 10 - Drivers of Cost in Cardiometabolic Management

Episode 9 - Current Challenges and Gaps in Patient Care

Episode 8 - A Diverse Patient Population and Its Challenges

Episode 7 - The Complex Equation of Management

Episode 6 - Diabetes and the Burden of Disease

Episode 5 - Setting the Tone: Current Therapeutic Goals

Episode 4 - The Link Between Diabetes and Cardiovascular Disease

Episode 2 - The Challenges of Disease Management: Clinician and Provider Perspectives

Episode 3 - The Diversity of Patient Populations

Episode 1 - The Prevalence of Comorbid Cardiometabolic Disorders in the US

Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants

Michael Farkouh, MD, Talks about the Prevention of Diabetes Mellitus

Diabetes Costs Nation $245 Billion Annually, Study Says

Type 2 Diabetes and the Evolving Paradigm in Glucose Regulation

Trending on AJMC

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

COVID Postexposure Prophylaxis Expands Prevention Toolkit: Noah Greenspan, DPT, PT

AI Reshaping Diabetes Care From Nutrition to Clinical Decisions